• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

水杨酸盐通过激活AMPK和抑制半胱天冬酶-6活性,逆转非酒精性脂肪性肝病小鼠模型中的代谢紊乱。

Salsalate reverses metabolic disorders in a mouse model of non-alcoholic fatty liver disease through AMPK activation and caspase-6 activity inhibition.

作者信息

Li Jingjing, Chen Changmai, Zhang Wei, Bi Jing'ai, Yang Guang, Li Erguang

机构信息

State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing University, Nanjing, China.

Jiangsu Key Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing, China.

出版信息

Basic Clin Pharmacol Toxicol. 2021 Mar;128(3):394-409. doi: 10.1111/bcpt.13535. Epub 2020 Nov 27.

DOI:10.1111/bcpt.13535
PMID:33200549
Abstract

Salsalate, an ester formed by 2 salicylic acid molecules, has beneficial effect against metabolic disorders in clinical trials and in animal studies. This study focused on the mechanistic aspects of salsalate activity against non-alcoholic fatty liver disease (NAFLD). Using high-fat diet (HFD) fed mice, we showed that salsalate treatment decreased body-weight gains, reduced white adipose tissue mass and improved glycaemic control. Mice in salsalate-treated group also had reduced obese adipose tissue and hepatic macrophage infiltration and inflammation and adipogenesis gene expression. Histology analysis revealed predominant decreases in hepatosteatosis, including both macrovesicular and microvesicular steatoses. The treatment reversed AMPK activity repression that was accompanied by reduced caspase-6 activity and cleavage. Enzymatic assay and cell culture studies showed that salsalate promoted AMPK activation by directly activating AMPK. This study links salsalate effect against metabolic disorders to its activity on reversion of AMPK repression in NAFLD mice and on suppression of adipogenic gene induction.

摘要

双水杨酸酯是由2个水杨酸分子形成的一种酯,在临床试验和动物研究中对代谢紊乱具有有益作用。本研究聚焦于双水杨酸酯抗非酒精性脂肪性肝病(NAFLD)活性的作用机制。使用高脂饮食(HFD)喂养的小鼠,我们发现双水杨酸酯治疗可降低体重增加、减少白色脂肪组织量并改善血糖控制。双水杨酸酯治疗组的小鼠还减少了肥胖脂肪组织和肝脏巨噬细胞浸润以及炎症和脂肪生成基因表达。组织学分析显示肝脂肪变性明显减轻,包括大泡性和小泡性脂肪变性。该治疗逆转了伴随半胱天冬酶-6活性和切割减少的AMPK活性抑制。酶活性测定和细胞培养研究表明,双水杨酸酯通过直接激活AMPK促进AMPK活化。本研究将双水杨酸酯对代谢紊乱的作用与其对NAFLD小鼠中AMPK抑制的逆转活性以及对脂肪生成基因诱导的抑制联系起来。

相似文献

1
Salsalate reverses metabolic disorders in a mouse model of non-alcoholic fatty liver disease through AMPK activation and caspase-6 activity inhibition.水杨酸盐通过激活AMPK和抑制半胱天冬酶-6活性,逆转非酒精性脂肪性肝病小鼠模型中的代谢紊乱。
Basic Clin Pharmacol Toxicol. 2021 Mar;128(3):394-409. doi: 10.1111/bcpt.13535. Epub 2020 Nov 27.
2
Salsalate and adiponectin ameliorate hepatic steatosis by inhibition of the hepatokine fetuin-A.水杨酸盐和脂联素通过抑制肝源性激素胎球蛋白-A 改善肝脂肪变性。
Biochem Pharmacol. 2013 Oct 1;86(7):960-9. doi: 10.1016/j.bcp.2013.07.034. Epub 2013 Aug 13.
3
Salsalate attenuates diet induced non-alcoholic steatohepatitis in mice by decreasing lipogenic and inflammatory processes.水杨酸盐通过减少脂肪生成和炎症过程减轻饮食诱导的小鼠非酒精性脂肪性肝炎。
Br J Pharmacol. 2015 Nov;172(22):5293-305. doi: 10.1111/bph.13315. Epub 2015 Oct 22.
4
Salsalate (Salicylate) Uncouples Mitochondria, Improves Glucose Homeostasis, and Reduces Liver Lipids Independent of AMPK-β1.双水杨酯(水杨酸盐)可使线粒体解偶联,改善葡萄糖稳态,并降低肝脏脂质,且不依赖于AMPK-β1。
Diabetes. 2016 Nov;65(11):3352-3361. doi: 10.2337/db16-0564. Epub 2016 Aug 23.
5
Demethyleneberberine attenuates non-alcoholic fatty liver disease with activation of AMPK and inhibition of oxidative stress.去甲基小檗碱通过激活AMPK和抑制氧化应激减轻非酒精性脂肪性肝病。
Biochem Biophys Res Commun. 2016 Apr 15;472(4):603-9. doi: 10.1016/j.bbrc.2016.03.019. Epub 2016 Mar 9.
6
The Dipeptidyl Peptidase-4 Inhibitor Teneligliptin Attenuates Hepatic Lipogenesis via AMPK Activation in Non-Alcoholic Fatty Liver Disease Model Mice.二肽基肽酶-4抑制剂替格列汀通过激活非酒精性脂肪性肝病模型小鼠的AMPK减轻肝脏脂肪生成。
Int J Mol Sci. 2015 Dec 8;16(12):29207-18. doi: 10.3390/ijms161226156.
7
Salsalate and Adiponectin Improve Palmitate-Induced Insulin Resistance via Inhibition of Selenoprotein P through the AMPK-FOXO1α Pathway.水杨酸盐和脂联素通过AMPK-FOXO1α途径抑制硒蛋白P改善棕榈酸诱导的胰岛素抵抗。
PLoS One. 2013 Jun 18;8(6):e66529. doi: 10.1371/journal.pone.0066529. Print 2013.
8
Green tea polyphenols ameliorate non-alcoholic fatty liver disease through upregulating AMPK activation in high fat fed Zucker fatty rats.绿茶多酚通过上调高脂喂养的 Zucker 肥胖大鼠的 AMPK 激活来改善非酒精性脂肪性肝病。
World J Gastroenterol. 2017 Jun 7;23(21):3805-3814. doi: 10.3748/wjg.v23.i21.3805.
9
(S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation.新型异喹啉生物碱(S)YS - 51通过抑制脂肪生成、炎症和凝血来减轻小鼠肥胖相关的非酒精性脂肪性肝病。
Eur J Pharmacol. 2016 Oct 5;788:200-209. doi: 10.1016/j.ejphar.2016.06.040. Epub 2016 Jun 23.
10
Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.心肌营养素-1 通过激活 AMPK 的机制消除肥胖小鼠的肝脂肪变性。
J Hepatol. 2014 May;60(5):1017-25. doi: 10.1016/j.jhep.2013.12.012. Epub 2013 Dec 19.

引用本文的文献

1
Comprehensive Analysis Reveals the Molecular Features and Immune Infiltration of PANoptosis-Related Genes in Metabolic Dysfunction-Associated Steatotic Liver Disease.综合分析揭示代谢功能障碍相关脂肪性肝病中PAN细胞焦亡相关基因的分子特征和免疫浸润
Biology (Basel). 2025 May 8;14(5):518. doi: 10.3390/biology14050518.
2
New Insights into AMPK, as a Potential Therapeutic Target in Metabolic Dysfunction-Associated Steatotic Liver Disease and Hepatic Fibrosis.AMPK作为代谢功能障碍相关脂肪性肝病和肝纤维化潜在治疗靶点的新见解
Biomol Ther (Seoul). 2025 Jan 1;33(1):18-38. doi: 10.4062/biomolther.2024.188. Epub 2024 Dec 20.
3
Salicylate induces epithelial actin reorganization via activation of the AMP-activated protein kinase and promotes wound healing and contraction in mice.
水杨酸盐通过激活 AMP 激活的蛋白激酶诱导上皮细胞肌动蛋白重排,并促进小鼠的伤口愈合和收缩。
Sci Rep. 2024 Jul 16;14(1):16442. doi: 10.1038/s41598-024-67266-5.
4
NUAK1 promotes metabolic dysfunction-associated steatohepatitis progression by activating Caspase 6-driven pyroptosis and inflammation.NUAK1 通过激活 Caspase 6 驱动的细胞焦亡和炎症促进代谢相关脂肪性肝炎的进展。
Hepatol Commun. 2024 Jul 5;8(7). doi: 10.1097/HC9.0000000000000479. eCollection 2024 Jul 1.
5
Exploring Promising Therapies for Non-Alcoholic Fatty Liver Disease: A ClinicalTrials.gov Analysis.探索非酒精性脂肪性肝病的潜在疗法:一项ClinicalTrials.gov分析
Diabetes Metab Syndr Obes. 2024 Feb 2;17:545-561. doi: 10.2147/DMSO.S448476. eCollection 2024.
6
Myosteatosis: Diagnosis, pathophysiology and consequences in metabolic dysfunction-associated steatotic liver disease.肌脂肪变性:代谢功能障碍相关脂肪性肝病的诊断、病理生理学及后果
JHEP Rep. 2023 Nov 14;6(2):100963. doi: 10.1016/j.jhepr.2023.100963. eCollection 2024 Feb.
7
Current insights in molecular characterization of non-alcoholic fatty liver disease and treatment.非酒精性脂肪性肝病的分子特征及治疗的最新研究进展。
Front Endocrinol (Lausanne). 2022 Nov 29;13:1002916. doi: 10.3389/fendo.2022.1002916. eCollection 2022.
8
Adenosine monophosphate activated protein kinase contributes to skeletal muscle health through the control of mitochondrial function.单磷酸腺苷激活蛋白激酶通过控制线粒体功能来促进骨骼肌健康。
Front Pharmacol. 2022 Oct 20;13:947387. doi: 10.3389/fphar.2022.947387. eCollection 2022.